- Home
- DSS vs IMRN Comparison
DSS vs IMRN Comparison
Compare DSS & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSS
- IMRN
- Stock Information
- Founded
- DSS 1984
- IMRN 1994
- Country
- DSS United States
- IMRN Australia
- Employees
- DSS N/A
- IMRN N/A
- Industry
- DSS Containers/Packaging
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- DSS Consumer Discretionary
- IMRN Health Care
- Exchange
- DSS Nasdaq
- IMRN Nasdaq
- Market Cap
- DSS 8.1M
- IMRN 9.2M
- IPO Year
- DSS N/A
- IMRN N/A
- Fundamental
- Price
- DSS $0.85
- IMRN $1.70
- Analyst Decision
- DSS
- IMRN Strong Buy
- Analyst Count
- DSS 0
- IMRN 1
- Target Price
- DSS N/A
- IMRN $5.00
- AVG Volume (30 Days)
- DSS 13.6K
- IMRN 53.0K
- Earning Date
- DSS 05-15-2025
- IMRN 06-17-2025
- Dividend Yield
- DSS N/A
- IMRN N/A
- EPS Growth
- DSS N/A
- IMRN N/A
- EPS
- DSS N/A
- IMRN N/A
- Revenue
- DSS $20,180,000.00
- IMRN $4,048,286.00
- Revenue This Year
- DSS N/A
- IMRN N/A
- Revenue Next Year
- DSS N/A
- IMRN N/A
- P/E Ratio
- DSS N/A
- IMRN N/A
- Revenue Growth
- DSS 12.88
- IMRN 82.90
- 52 Week Low
- DSS $0.72
- IMRN $1.50
- 52 Week High
- DSS $1.90
- IMRN $2.87
- Technical
- Relative Strength Index (RSI)
- DSS 43.41
- IMRN 43.37
- Support Level
- DSS $0.79
- IMRN $1.69
- Resistance Level
- DSS $0.89
- IMRN $1.89
- Average True Range (ATR)
- DSS 0.06
- IMRN 0.17
- MACD
- DSS -0.01
- IMRN -0.01
- Stochastic Oscillator
- DSS 63.77
- IMRN 34.06
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.